Single cell whole transcriptome analysis of disease cells to generate a targeted RNA-sequencing gene panel for the simultaneous analysis of targeted mRNA and protein

Nidhanjali Bansal,Hye-Won Song,Silin Sa,Woodrow E Lomas,Gisele V Baracho,Ian Taylor,Stephanie Widmann,Stefanie Mortimer
DOI: https://doi.org/10.4049/jimmunol.202.supp.131.35
2019-05-01
The Journal of Immunology
Abstract:Abstract Single cell RNA-sequencing (scRNA-seq) is a powerful tool for understanding the sample heterogeneity of individual cells. Many methods rely on whole transcriptome analysis (WTA) to get a snapshot of the entire cellular landscape. Although WTA analysis can be used to discover novel biomarkers, this technique can be expensive. To enable scaling of experiments, WTA data can be mined to design targeted gene panels. To showcase this, we used single cell sequencing to examine thousands of B cells isolated from the bone marrow and peripheral blood of chronic lymphocytic leukemia (CLL) and healthy donors. B cells that had been sorted using the BD FACSMelodyTM cell sorter were multiplexed using the BDTM Human Single-Cell Multiplexing Kit and pooled before being processed on the BD RhapsodyTM system, thereby minimizing batch effects. The resulting data was mined to design a panel of differentially expressed genes between CLL and healthy B cells that could be used for subsequent CLL phenotyping. By combining this panel with the BD RhapsodyTM Immune Response Panel (together comprising ~500 mRNAs), along with 36 DNA-barcoded BDTM AbSeq antibodies, we were able to simultaneously analyze mRNA and protein targets from a new subset of CLL and healthy B cells for additional high-resolution analysis. This study showcases the power of using WTA data to design specific gene panels that can be used alone or in combination with existing targeted panels for routine and cost-effective transcriptional profiling at a single cell level. For Research Use Only. Not for use in diagnostic or therapeutic procedures. BD, the BD Logo, FACSMelody, and Rhapsody are trademarks of Becton, Dickinson and Company. © 2019 BD and its subsidiaries. All rights reserved.
immunology
What problem does this paper attempt to address?